Home

purdue pharma tapes

OxyContin: The Truth Behind the Hulu's 'Dopesick'
OxyContin: The Truth Behind the Hulu's 'Dopesick'

A story people need to know': behind a shocking TV series about the opioid  crisis | US television | The Guardian
A story people need to know': behind a shocking TV series about the opioid crisis | US television | The Guardian

Every Time I Thought the Purdue Pharma OxyContin Story Was Over, I Was  Wrong - The New York Times
Every Time I Thought the Purdue Pharma OxyContin Story Was Over, I Was Wrong - The New York Times

Judge conditionally approves Purdue Pharma opioid settlement
Judge conditionally approves Purdue Pharma opioid settlement

Purdue's Demise Could Be A New Beginning For The Pharmaceutical Industry |  Health Affairs
Purdue's Demise Could Be A New Beginning For The Pharmaceutical Industry | Health Affairs

One year after OxyContin launched, Purdue Pharma execs applied to patent  'self-destructing' emails - ABC News
One year after OxyContin launched, Purdue Pharma execs applied to patent 'self-destructing' emails - ABC News

Dopesick casts the Sacklers and Purdue Pharma as villains of the opioid  crisis : NPR
Dopesick casts the Sacklers and Purdue Pharma as villains of the opioid crisis : NPR

Opioid Training Used 'Deceptive' Salesmen Movie
Opioid Training Used 'Deceptive' Salesmen Movie

US Supreme Court halts Purdue's $6 billion opioid pact, will hear appeal |  Business News | ArcaMax Publishing
US Supreme Court halts Purdue's $6 billion opioid pact, will hear appeal | Business News | ArcaMax Publishing

Sacklers agree to new $6bn Purdue US settlement over opioids
Sacklers agree to new $6bn Purdue US settlement over opioids

Bharara: Tape makes 'very, very clear' Trump couldn't declassify  'telepathically' | The Hill
Bharara: Tape makes 'very, very clear' Trump couldn't declassify 'telepathically' | The Hill

Faced with fears of OxyContin misuse, sales reps touted its safety - STAT
Faced with fears of OxyContin misuse, sales reps touted its safety - STAT

What opioid victims told Sacklers when they got the chance | The Seattle  Times
What opioid victims told Sacklers when they got the chance | The Seattle Times

Legal shield for Purdue Pharma owners is at heart of appeals
Legal shield for Purdue Pharma owners is at heart of appeals

Every Time I Thought the Purdue Pharma OxyContin Story Was Over, I Was  Wrong - The New York Times
Every Time I Thought the Purdue Pharma OxyContin Story Was Over, I Was Wrong - The New York Times

South Carolina files lawsuit against manufacturer of OxyContin - Purdue  Pharma in worsening opioid crisis | News | postandcourier.com
South Carolina files lawsuit against manufacturer of OxyContin - Purdue Pharma in worsening opioid crisis | News | postandcourier.com

Recap: Dopesick Episodes 8 “The People vs. Purdue Pharma” (Hulu) -  LaughingPlace.com
Recap: Dopesick Episodes 8 “The People vs. Purdue Pharma” (Hulu) - LaughingPlace.com

Ex-head of Purdue denies responsibility for opioid crisis
Ex-head of Purdue denies responsibility for opioid crisis

Recap: Dopesick Episodes 8 “The People vs. Purdue Pharma” (Hulu) -  LaughingPlace.com
Recap: Dopesick Episodes 8 “The People vs. Purdue Pharma” (Hulu) - LaughingPlace.com

A story people need to know': behind a shocking TV series about the opioid  crisis | US television | The Guardian
A story people need to know': behind a shocking TV series about the opioid crisis | US television | The Guardian

OxyContin maker Purdue Pharma launches campaign for opioid victims to file  claims
OxyContin maker Purdue Pharma launches campaign for opioid victims to file claims

PBS NewsHour | Purdue Pharma family protected from lawsuits in settlement |  Season 2023 | PBS
PBS NewsHour | Purdue Pharma family protected from lawsuits in settlement | Season 2023 | PBS

Narcotic Maker Guilty of Deceit Over Marketing - The New York Times
Narcotic Maker Guilty of Deceit Over Marketing - The New York Times

Purdue Pharma used deceptive sales tactic for OxyContin after settlement,  ex-sales rep says - CBS News
Purdue Pharma used deceptive sales tactic for OxyContin after settlement, ex-sales rep says - CBS News

An Insider from the Purdue Pharma Bankruptcy Speaks Out | The New Yorker
An Insider from the Purdue Pharma Bankruptcy Speaks Out | The New Yorker